You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inflammatory Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

Not yet recruiting
  • Inflammatory Breast Cancer
  • Breast conserving surgery
  • Radical modified mastectomy
  • (no location specified)
Nov 14, 2023

Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab

Not yet recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 20, 2023

Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,

Active, not recruiting
Has Results
  • Inflammatory Breast Cancer
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Tumors Trial in Knoxville (Self-Administered Hypnosis,

Recruiting
  • Breast Cancer
  • +4 more
  • Self-Administered Hypnosis
  • Self-Administered White Noise Hypnosis
  • Knoxville, Tennessee
    University of Tennessee Knoxville
Sep 26, 2023

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)

Recruiting
  • Breast Cancer
  • +5 more
  • MRI
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 9, 2022

Tumor Biopsy in Creating Research Tissue Registry in

Recruiting
  • Inflammatory Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Houston, Texas
  • +4 more
Jan 6, 2023

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in

Active, not recruiting
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • +4 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Breast Inflammatory Carcinoma, Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston

Recruiting
  • Breast Inflammatory Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2022

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Breast Cancer Trial in Boston, Ann Arbor (drug, procedure, radiation)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
May 2, 2022

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Breast Cancer Trial in Bloomington, New York (Nivolumab 360mg, Paclitaxel 80mg/m^2, Doxorubicin 60mg/m^2)

Completed
Has Results
  • Breast Cancer
  • Nivolumab 360mg
  • +6 more
  • Bloomington, Indiana
  • +1 more
Feb 2, 2022

Breast Cancer Trial (Gemcitabine, Epirubicin, Docetaxel)

Completed
Has Results
  • Breast Cancer
  • (no location specified)
Oct 4, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 16, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Chicago, Illinois
    Northwestern University
Oct 13, 2021

Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jul 18, 2022

    Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

    Active, not recruiting
    • Inflammatory Breast Cancer
    • +9 more
    • External beam radiation therapy
    • New Brunswick, New Jersey
    • +1 more
    Jan 30, 2022

    Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston (Atezolizumab, Cobimetinib,

    Recruiting
    • Recurrent Breast Inflammatory Carcinoma
    • Stage IV Breast Inflammatory Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 11, 2021

    Breast Cancer Trial in Toronto

    Recruiting
    • Breast Cancer
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre-Odette Cancer Centre
      Jan 10, 2023

      Individual Radiosensitivity During Radiotherapy for Breast

      Recruiting
      • Radiation Tolerance
      • Breast Neoplasms
      • Blood sample
      • Stockholm, Sweden
        Karolinska University Hospital
      Oct 2, 2022

      Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

      Completed
      • Cancer, Treatment-Related
      • +3 more
      • cryoablation
      • Roma, Italy
        Sapienza University of Rome
      Feb 13, 2023

      Breast Cancer Trial in Taichung (Diclofenac)

      Completed
      • Breast Cancer
      • Taichung, Taiwan
        China Medical University Hospital
      Jul 18, 2022

      Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

      Active, not recruiting
      • Anatomic Stage IIB Breast Cancer AJCC v8
      • +19 more
      • Gilbert, Arizona
      • +4 more
      Dec 6, 2022